Who May Qualify:
- 18-80 years of age
- have type 1 or type 2 diabetes
- experience foot pain and numbness
- confirmed diagnosis of diabetic peripheral neuropathy
Qualified participants may receive:
- Access to innovative treatments
- Expert medical care under close supervision
- Possible compensation for time and travel
Diabetic Neuropathy Clinical Trials Contribute in Big Ways
Managing diabetic neuropathy effectively begins with understanding its symptoms, exploring available treatment options, and taking steps to support healthy nerve function and blood sugar control. Because nerve damage can progress over time, early awareness and ongoing care are important for reducing discomfort and preventing further complications.
Choosing the right care approach may involve evaluating pain management strategies, glucose control, lifestyle adjustments, and emerging treatment options. Each person’s experience with diabetic neuropathy is different, so learning about available therapies can help individuals and their healthcare providers make informed decisions that support long-term health and quality of life.
Our clinical trials are designed to evaluate potential new treatments for diabetic neuropathy, focusing on improving nerve health, reducing symptoms such as pain or numbness, and advancing safer, more effective treatment options for people living with diabetes.
What Participants Are Saying
How Clinical Trials Work
Our goal is to provide a seamless process for patients and caregivers
1
Recruiting Participants
Our team recruits, qualifies, and retains volunteers for a variety of clinical trials. We are dedicated to providing our clinics with a diverse selection of qualified participants, and maintain the highest level of ethics and privacy.
2
Conducting Clinical Trials
Trials are conducted based on the protocols determined by the trial’s sponsor, ensuring that even if trials are completed at multiple locations, the integrity of the study is maintained.
3
Analyzing Results
Our clinics collect and verify detailed medical data during clinical trials and report preliminary results to the sponsor. We never share personally identifiable information (PII) and only report consented medical data.